Showing results (971-980 of 4,634) with videos related to
Sort By:
Pageof 464
Anti-Cancer Drugs|March 16, 2019
Selenium attenuates docetaxel-induced apoptosis and mitochondrial oxidative stress in kidney cellsErcan Baş, Mustafa NaziroğluAnti-Cancer Drugs|November 22, 2018
Toward stimulating apoptosis in human lung adenocarcinoma cells by novel nano-carmofur compound treatmentEmre Çömlekçi, Hatice M Kutlu, Canan Vejselova SezerAnti-Cancer Drugs|March 29, 2019
APLNR promotes the progression of osteosarcoma by stimulating cell proliferation and invasionLei Cui, Jing-Yuan Zhang, Zhi-Peng Ren, et al.Anti-Cancer Drugs|April 22, 2017
Bortezomib pharmacokinetics in tumor response and peripheral neuropathy in multiple myeloma patients receiving bortezomib-containing therapySung-Eun Lee, Kyungmee Choi, Seunghoon Han, et al.Anti-Cancer Drugs|March 22, 2019
Knockdown of long noncoding RNA-taurine-upregulated gene 1 inhibits tumor angiogenesis in ovarian cancer by regulating leucine-rich α-2-glycoprotein-1Mingjun Fan, Chunyan Li, Pengjuan He, et al.Anti-Cancer Drugs|July 16, 2019
Andrographolide sensitizes Hep-2 human laryngeal cancer cells to carboplatin-induced apoptosis by increasing reactive oxygen species levelsWenjing Mao, Peijie He, Weicheng Wang, et al.Anti-Cancer Drugs|July 16, 2019
Pharmacokinetics of pertuzumab administered concurrently with trastuzumab in Chinese patients with HER2-positive early breast cancerYang Luo, Wei Li, Zefei Jiang, et al.Anti-Cancer Drugs|July 16, 2019
Poor outcome for patients with gastric cancer and lung metastases treated with ramucirumab and paclitaxelGiandomenico Roviello, Silvia P Corona, Andrea G Multari, et al.Anti-Cancer Drugs|July 16, 2019
Efficacy and safety of apatinib in advanced sarcoma: an open-label, nonrandomized, single-center study of 45 patientsYao Weitao, Wu Fangxing, Cai Qiqing, et al.Anti-Cancer Drugs|June 6, 2008
Phase II trial of oxaliplatin combined with leucovorin and fluorouracil for recurrent/metastatic biliary tract carcinomaJae Yun Lim, Hei-Cheul Jeung, Hee Sun Mun, et al.Pageof 464